000064484 001__ 64484
000064484 005__ 20220120225830.0
000064484 0247_ $$2doi$$a10.1016/j.jad.2015.11.042
000064484 0248_ $$2sideral$$a93242
000064484 037__ $$aART-2016-93242
000064484 041__ $$aeng
000064484 100__ $$aRodríguez-Cano, R.
000064484 245__ $$aSmoking cessation and depressive symptoms at 1-, 3-, 6-, and 12-months follow-up
000064484 260__ $$c2016
000064484 5060_ $$aAccess copy available to the general public$$fUnrestricted
000064484 5203_ $$aBackground The relationship between tobacco and depressive symptoms has been examined. However, there is little information on the evolution of these symptoms when an individual quits. The aim of this study was to analyze the evolution of depressive symptoms over time (pre-, post-treatment, 1-, 3-, 6-, and 12-months follow-up) in relation to smoking status 12 months after having received a psychological treatment for smoking cessation. Method The sample was made up of 242 adults who received cognitive-behavioral treatment for smoking cessation (64.4% women; mean age=41.71 years). The BDI-II was used to assess depressive symptomatology. Participants were classified into three groups according to smoking status at 12-months follow-up (abstainers, relapsers, and smokers). Results There were no significant differences in depressive symptoms among the three groups at pretreatment. At the end of treatment, abstainers and relapsers presented less depressive symptomatology than smokers. At follow-up, abstainers continued to present less depressive symptomatology than smokers, whereas in relapsers, symptoms began to increase as the relapses occurred. Regarding the evolution of depressive symptomatology, the abstainer and relapser groups showed a significant reduction at the end of treatment. Only in the group of abstainers did the decrease continue during 12 months follow-up. Limitations The decrease of the initial sample size from 562 to 242 participants. Variables such as self-esteem and self-efficacy were not assessed. Conclusions Smoking cessation is associated with a decrease in depressive symptomatology, that is maintained over time. In contrast, relapse is associated with an increase of such symptoms. These findings signify the potential importance of addressing depressive symptomatology in smoking cessation treatment.
000064484 536__ $$9info:eu-repo/grantAgreement/ES/MINECO/PSI2012-31196
000064484 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
000064484 590__ $$a3.432$$b2016
000064484 591__ $$aPSYCHIATRY$$b26 / 139 = 0.187$$c2016$$dQ1$$eT1
000064484 591__ $$aCLINICAL NEUROLOGY$$b55 / 194 = 0.284$$c2016$$dQ2$$eT1
000064484 591__ $$aPSYCHOLOGY, EXPERIMENTAL$$b43 / 142 = 0.303$$c2016$$dQ2$$eT1
000064484 592__ $$a2.016$$b2016
000064484 593__ $$aPsychiatry and Mental Health$$c2016$$dQ1
000064484 593__ $$aClinical Psychology$$c2016$$dQ1
000064484 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/acceptedVersion
000064484 700__ $$aLópez-Durán, A.
000064484 700__ $$0(orcid)0000-0002-9645-8109$$aFernández Del Río, E.$$uUniversidad de Zaragoza
000064484 700__ $$aMartínez-Vispo, C.
000064484 700__ $$aMartínez, Ú.
000064484 700__ $$aBecoña, E.
000064484 7102_ $$14009$$2740$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicología Social
000064484 773__ $$g191 (2016), 94-99$$pJ. affect. disord.$$tJournal of Affective Disorders$$x0165-0327
000064484 8564_ $$s367494$$uhttps://zaguan.unizar.es/record/64484/files/texto_completo.pdf$$yPostprint
000064484 8564_ $$s114412$$uhttps://zaguan.unizar.es/record/64484/files/texto_completo.jpg?subformat=icon$$xicon$$yPostprint
000064484 909CO $$ooai:zaguan.unizar.es:64484$$particulos$$pdriver
000064484 951__ $$a2022-01-20-22:53:33
000064484 980__ $$aARTICLE